Would you give post-mastectomy radiation for a T2N1 triple negative BRCA 2+ patient who had a complete response from neoadjuvant chemo?

When B51 was opened, we offered that. Otherwise, outside clinical trial triple negative with node positive disease recommend PMRT irrespective of response to NACT.